chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I am worried that the vaccine has messed up my immune system and caused my RA to come back; I am worried that the vaccine has messed up my immune system; My fingers started swelling; The pain and swelling in my hands is now excruciating and it is starting in my feet; My fingers are starting to twist and curl; This is a spontaneous report from a contactable consumer or other non hcp (patient, self-reporting). A 57-year-old non pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6203 and expiration date was not reported), via an unspecified route of administration in arm left on 04Mar2021 at 12:30 as dose 2, single (age at vaccination 57-year-old) for COVID-19 immunisation. Medical history included rheumatoid arthritis from an unknown date, Thyroid Disease from an unknown, Hashimotos from an unknown date. The patient previously took levaquin and experienced hypersensitivity. Historical vaccine information included first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number EL9261), via an unspecified route of administration in arm left on 12Feb2021 at 12:15 PM for COVID-19 Immunization. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received other medications within 2 weeks of vaccination includes compounded Thyroid med, compounded est/test cream. The patient reported that worried that the vaccine has messed up her immune system and caused RA to come back, her fingers started swelling, the pain and swelling in her hands was now excruciating and it was starting in her feet, her fingers were starting to twist and curl on 10Apr2021. Patient had RA in the past but had been in remission for over a year and a half. About a month after getting the 2nd COVID vaccination her fingers started swelling and hurting. The pain and swelling in her hands was excruciating and it was starting in her feet. Her fingers were starting to twist and curl. She was worried that the vaccine has messed up her immune system and caused her RA to come back way worse than it ever was. This was coming on fast and very severe. She won't be able to work much longer if something wasn't done to reverse the pain and damage. The patient underwent lab tests and procedures which included x-ray: unknown on an unknown date. Therapeutic measures were taken as a result of events includes medication for the pain and inflammation, x rays. The outcome of the events were not resolved.  Follow-up actions are needed. Further information has been requested.
The patient reports within approximately 2 days of receiving the first dose of Shingrix he experienced loss of feeling in his left index finger.  Since then he has experienced continued loss of feeling and also a burning, tingling sensation that has woken him up most nights.  The patient stated he has not discussed  this with his healthcare provider.    The patient reports the vaccine was administered in his left deltoid but the pharmacy documentation states it was given in right deltoid.
I experienced an outbreak of hives on my legs, feet, arms, hands, and ears. I took Benadryl to minimize the itching and burning of them. I first noticed them when I was showering on my lower legs on the morning of April 23rd. They flared up the most on April 24th for about a 24 hour period and begin to subside on April 25th and 26th. They are still present but slowing diminishing.
10 days (4/5/2021) after receiving the shot (3/26/2021), I noticed the area around the injection site was a faint shade of red & mildly itchy. I called my primary care physician and was seen that afternoon by her partner. Doctor examined my arm & recommended that I start applying  Benadryl & Hydrocortisone cream every 4 hrs alternating between the two. If the affected area gets worse, I am to call the office immediately. If it does not improve within 3 days, I am to call my dermatologist. This redness is in addition to swelling in my upper arm that has been present since the injection. While the initial soreness lasted only a few days, the swelling has been constant - not getting any worse, but not getting any better. For the swelling, doctor  suggested trying to minimize use of my arm to help it heal.
Shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, several days after receiving Shingles vaccine, the patient experienced shingles (Verbatim: Shingles). The outcome of the shingles was not reported.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     It was unknown if the company considered the shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 17-MAR-2023 This case was reported by a patient via interactive digital media. The reporter reported that a year before the pandemic his or her physician was vigorously pressuring him or her to get the shingles vaccine. The reporter stated that in 2021 his or her coworker who was 20 years younger than him or her experienced shingles right after received Shingles vaccine as did many other recently vaccinated peoples. Follow-up would not possible as no contact details were available.
This spontaneous report was received from a nurse practitioner refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions, allergies and concomitant therapy were unknown. On 25-APR-2018 the patient was vaccinated with expired dose of, VAQTA (dose, units and frequency unknown) (lot # N005605 and expiration date 08-APR-2018). No adverse effects reported. No product quality complaint was reported. This is one of the two reports received from the same reporter.
This is a 44 Years old male c/o right sided facial weakness for 3 days. Patient states facial weakness started 3 days ago. He complains of difficulty raising his right eye brow and closing his right eye completely. No changes in taste sensation or vision, no ear pain, no weakness in both arms or legs. He did not get sick recently prior to his facial weakness. He has no problem walking or his gait. He denies nausea, vomiting, or headache. Denies chest pain, palpitations, shortness of breath or dizziness.  He was COVID-19 positive on 1/16/21 and received his first dose on 4/3/21.  PMH: No chornic medication condition No hx surgery  General: alert & orientedx3, no acute distress, cooperative, speech clear anbd coherent Neuro: cranial nerves intact EXCEPT CN VII mild right sided facial weakness w/ difficulty raising right eye brow and incomplete closure of right eye, positive numbness on CN VII V1-V3 Gait: normal tandem gait, negative Romberg Strength: 5/5 strength of both upper extremities, 5/5 strength of both lower extremities, no atrophy Sensation: intact to light touch both upper extremities, intact to light touch both lower extremities Cerebellar: no ataxia Reflexes: 2+ B patellar Head: normocephalic, without obvious abnormality, atraumatic Eyes: PERRLA, EOMI Ears: TM intact w/ grayish in color, no bulging, redness or discharge Nose: inferior turbinates pink and moist Throat: lips, mucosa, and tongue normal; teeth and gums normal Neck: no adenopathy and thyroid not enlarged, symmetric, no tenderness/mass/nodules Lungs:clear to auscultation bilaterally, no rales/rhonchi/wheezes, good air movement Heart: regular rate, regular rhythm, no murmur, normal S1/S2 Extremities: extremities normal, atraumatic, no cyanosis or edema  Assessment/Plan 1. Bell palsy, Bell palsy -CN VII facial weakness/numbness sudden onset, difficulty closing right eye c/w Bell's palsy -PO Steroid and acyclovir for 7 days plus eye lubricant for 14 days -F/U PCP in 5 days -Consider ophthalmologist if no improvement with eye closure or facial motor
pt recv vax in rt hip @ pts request instead of deltoid; noticed a knot on hip that evening; had h/a & sl fever 7JUL95; itching @ inj site; knot measured 7.5cm; itches
I experienced sharp chest pains that started in the upper center of my chest and traveled to my arm and legs, lightheadedness and headaches.
presented to office w/ c/o being fussy, green nasal drainage;rash all over the body x 1 days;
Information has been received from a nurse practitioner concerning an 18 year old female with penicillin allergy who on unspecified dates was vaccinated with the first and second doses of GARDASIL. In October 2007, was vaccinated with a third dose of GARDASIL. Concomitant therapy included hormonal contraceptives (unspecified). In October 2007, the day after administration of her third dose, the patient developed pruritic urticaria in different areas of her body every day. An skin biopsy was performed on 21-JUL-2008 and the results showed urticarial lesion due to systemic antigen including drug. She has been treated with steroid dose packs, antihistamine and KENALOG INJECTIONS. She has been also examined by an allergist but the information is not available. At time reporting, the patient had not recovered. Additional information has been requested.
04/17/2021 Because I have some risks factors, I had to wait full 30 min after vaccine. Once that was over, I got in my car to drive home, 45 min drive, I was on the phone with my mom and she started getting worried about me during the drive because I was telling her I was feeling lightheaded and brain foggy. I started feeling dyspeptic. It also happened after the first vaccine. Felt I would just be a little unwell for a day or so. When I got home, I was feeling pretty unwell, cold and could not warm up. At some point, 2 hours later, evening that day, I made a bowl of soup for myself. After I ate the bowl of soup, things began to develop rapidly in a bad direction. By that night, I was in more pain than I had been in my entire life and incredibly nauseated. The pain was in all the muscles and joints in my body. It felt like a really bad cramp in every muscle. This continued until the next morning. Vomited many times, perhaps 6 times or more. It was so bad, I was calling out to God to take me. I could not bear it or take it. My husband, at the time, was going through cancer treatment and I had to call him for help, I could not stand or sit up. I don't know how many days it took me to feel normal. It took at least 2 weeks to recover. Did not go to ER that night because my husband could not drive me and I was too incapacitated.
Took the vaccine on a Tuesday. Since Saturday morning, have been having constant vertigo. Every few minutes, I feel dizzy (sometimes triggered by head movement) accompanied by a general sense of imbalance. I don't have any history this kind of dizziness before.
Rapid heart rate during resting; Pain in jaw and face muscles; Pain in jaw and face muscles; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 04Sep2021 at 10:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vitamins (unspecified) and supplements (unspecified); both for an unknown indication from an unknown date and unknown if ongoing. On 05Sep2021 at 08:00, the patient experienced rapid heart rate during resting, pain in jaw and face muscles. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rapid heart rate during resting, pain in jaw and face muscles were recovering at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnant) in a 36-year-old female patient (gravida 4) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     The patient's past medical history included Abortion (spontaneous abortion in previous 3 pregnancies), Subfertility (used egg fertilization but had spontaneous pregnancy) and Alcohol use (5 to 6 week). Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] and MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 17-Sep-2020 and the estimated date of delivery was 24-Jun-2021. On 15-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-fifth week of the pregnancy.  On 15-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (pregnant) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Oct-2020, Pregnancy test: positive (Positive) Positive. On an unknown date, Glucose tolerance test: normal (normal) normal. On an unknown date, Ultrasound scan: abnormal (abnormal) before vaccine, 1 fetus has club foot with ankle.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient has a prior use of alcohol, 5 to 6 drinks per week.  Estimated date of conception was 25 Sep 2020.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-086234 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-086234:pregnancy
Breakthrough admission after 5 vaccines Moderna 2/19/21 Lot# 015M20A;  Moderna 3/19/21 Lot# 015M20A;  Moderna 10/26/21 Lot# 076C21A;  Moderna 4/26/22 Lot# 002M21A;  MOderna 10/14/22 Lot# 049D22A
Headache; soreness around injection site; Dose received: 3, product: COVID 19, brand: Pfizer; This is a spontaneous report received from a contactable reporter(s) (Pharmacist). The reporter is the patient.  A 30 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 09Dec2021 (Lot number: FF8839) at the age of 30 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL3247), for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3247), for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 09Dec2021, outcome "unknown", described as "Dose received: 3, product: COVID 19, brand: Pfizer"; HEADACHE (non-serious) with onset 10Dec2021, outcome "recovered" (2021), described as "Headache"; VACCINATION SITE PAIN (non-serious) with onset 10Dec2021, outcome "recovered" (2021), described as "soreness around injection site". Therapeutic measures were not taken as a result of headache, vaccination site pain.  Additional information: The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The reporter classified the events as non-serious.  No follow-up attempts are possible. No further information is expected.
The patient reported the event to us the week of 11/19/21- She reported tingling at the injection site and down the arm. She was seen by her primary care physician in between that time- he prescribed a systemic steroid anti-inflammatory. From her description, she was still able to use the arm under usual activity.
tested positive for COVID-19; This is a spontaneous report from a contactable consumer (patient) via the medical information team. A 55-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot and expiry were not reported), via an unspecified route of administration on 06Mar2021 as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received the first dose of bnt162b2 on 06Mar2021. She started having symptoms of COVID-19 on 09Mar2021 and then tested positive for COVID-19 on 11Mar2021. She would like to know what she should do about receiving her second dose of bnt162b2. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
This spontaneous report as received from a physician refers to a 68 year old male patient. The patient had None Pertinent Medical history and drug reactions/allergies. On 22-JUL-2013 the patient was vaccinated with PNEUMOVAX23 (25mcg/0.5ml) lot # J001180, exp. date: 18-AUG-2014, 0.5 ml, intramuscular. The reporter stated that the patient had and extensive list of medications (not specified). On 24-JUL-2013, 3 days after onset of therapy the patient experienced erythema and tenderness surrounding the injection site after receiving PNEUMOVAX23. The patient called the physician on 25-JUL-2013 and informed about adverse events. The patient sought medical attention on 25-JUL-2013 afternoon. The physician marked erythema area surrounding the injection site of PNEUMOVAX23. On 26-JUL-2013 the reported stated that the erythema spread past the mark. No lab test was performed. The doxycycline was prescribed to treat the adverse events. The patient would be seen again by the physician on 29-JUL-2013. The outcome of erythema and tenderness surrounding the injection site after receiving PNEUMOVAX23 was reported as not recovered/not resolved. The relatedness between PNEUMOVAX23 and adverse events was not reported. Additional information has been requested.
Within 1 hr of receiving Flu Vac pt developed hives on face (cheeks). No respiratory distress. Addendum 11/29/04: hives continued, still had them on 11/24/04 and pt vomited x 2 on 11/24/04; continuing with Benadryl q 5-6hrs.
Urticaria rash within 2 mins of administration of vaccine. Generalized rash, no respiratory difficulties. Resolved after Benadryl given.
swollen lymph node in collarbone; 3-4 nodules in her left bicep, the same arm where vaccine was given; Off label use; interchange of vaccine products; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), in Nov2021 as dose 2 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Janssen covid-19 vaccine (1st vaccine was J&J), for COVID-19 Immunization. The following information was reported: OFF LABEL USE (non-serious) with onset Nov2021, outcome "unknown"; INTERCHANGE OF VACCINE PRODUCTS (non-serious) with onset Nov2021, outcome "unknown"; LYMPHADENOPATHY (non-serious), outcome "recovered", described as "swollen lymph node in collarbone"; INJECTION SITE NODULE (non-serious), outcome "not recovered", described as "3-4 nodules in her left bicep, the same arm where vaccine was given". The event "3-4 nodules in her left bicep, the same arm where vaccine was given" required physician office visit. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.  Additional information: Pfizer COVID 19 Vaccine - Adult formulation, booster in Nov2021, Not Omicron formulation per patient. Purple or Gray cap formulation not confirmed by patient other than date of vaccination. Patient noted that this would be her 2nd dose total, but also referred to as her booster dose. 1st vaccine was J&J. The patient was told that where these nodules were not her lymph nodes. She was looking for guidance outside of lymph node concerns following the vaccination. Doctors didn't know she stated so she then spoke with her pharmacist who told her to call Pfizer to see if they have seen other issues. She did have a swollen lymph node in collarbone, that has since went down. She now reported having 3-4 nodules in her left bicep, the same arm where vaccine was given. That is where her concern is at this time she stated. It has been over one year and now she had at least 3 and she verbalized concerns of not getting answers.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient did not meet age requirements to receive the Covid booster. Patient did not have any adverse reactions. Patients' parents were notified.
This case was reported by a consumer via call center representative and described the occurrence of fever in a 64-year-old male patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (1st dose was received on 11th July 2018). On 13th November 2018, the patient received the 2nd dose of SHINGRIX. In November 2018, less than a day after receiving SHINGRIX, the patient experienced fever. On an unknown date, the outcome of the fever was not recovered/not resolved. It was unknown if the reporter considered the fever to be related to SHINGRIX. Additional details were provided as follows: On 13th November 2018, the patient received vaccine around 2 pm on right arm and noted just before midnight he had a fever. Not sure how high it was but noted it was worse than the morning of reporting date. On 14th November 2018, the patient noted his temperature was slightly over 100. The reporter was asked for healthcare professional information but never provided.
Began having hives covering my face. On monday 8/29 they started at around 3pm on my eyebrows and jawline and by 5pm my face was fully covered in Hives. On tuesday 8/30 I had small areas of hives come and go throughout the day, then at 3pm hives began developing as they did on monday until my face was fully covered. On Wed 9/1, I hadn't experienced any hive until 3pm. Then they began developing like the two days prior, all at around 3pm. I did not develop hives anywhere else then on my face.
This spontaneous report as received from a healthcare worker refers to a 3 month old patient of unknown gender. The patient's relevant medical history, current conditions and concomitant medications were not reported. On 04-NOV-2015 the patient was vaccinated with improperly stored ROTATEQ (dosing details were not reported) lot # L008053, with an expiry date of 30-NOV-2016, orally (incorrect product storage). The vaccine was administered at public health clinic or hospital with public funds. No adverse effects were reported. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Additional information has been requested.
3/27 got 1st pfizer vaccine in her right arm  had injection site pain for a week  and finally resolved  the next day woke up with severe right arm pain, hurts to lift it  sleeps on side and this also hurts it  no weakness but hurts to raise it up  no prior injuries  no trauma  pain in lateral shoulder, minimal neck pain, no pain distal to elbow  no numbness or tingling  on warfarin so has been afraid to take anything for this pain  5/10 at rest and much worse with movement